| Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment AC Bibby, S Tsim, N Kanellakis, H Ball, DC Talbot, KG Blyth, NA Maskell, ... European Respiratory Review 25 (142), 472-486, 2016 | 333 | 2016 |
| Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies JD Freedman, J Hagel, EM Scott, I Psallidas, A Gupta, L Spiers, P Miller, ... EMBO molecular medicine 9 (8), 1067-1087, 2017 | 129 | 2017 |
| Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis I Psallidas, NI Kanellakis, S Gerry, ML Thézénas, PD Charles, ... The Lancet Oncology 19 (7), 930-939, 2018 | 114 | 2018 |
| Mast cells mediate malignant pleural effusion formation AD Giannou, A Marazioti, M Spella, NI Kanellakis, H Apostolopoulou, ... The Journal of clinical investigation 125 (6), 2317-2334, 2015 | 112 | 2015 |
| Mutant KRAS promotes malignant pleural effusion formation T Agalioti, AD Giannou, AC Krontira, NI Kanellakis, D Kati, M Vreka, ... Nature communications 8 (1), 1-15, 2017 | 103 | 2017 |
| Licensing of DNA replication, cancer, pluripotency and differentiation: an interlinked world? SC Tsaniras, N Kanellakis, IE Symeonidou, P Nikolopoulou, Z Lygerou, ... Seminars in cell & developmental biology 30, 174-180, 2014 | 87 | 2014 |
| A pilot feasibility study in establishing the role of ultrasound-guided pleural biopsies in pleural infection (the AUDIO study) I Psallidas, NI Kanellakis, R Bhatnagar, R Ravindran, A Yousuf, AJ Edey, ... Chest 154 (4), 766-772, 2018 | 66 | 2018 |
| Club cells form lung adenocarcinomas and maintain the alveoli of adult mice M Spella, I Lilis, MAA Pepe, Y Chen, M Armaka, AS Lamort, DE Zazara, ... Elife 8, e45571, 2019 | 56 | 2019 |
| Iκb kinase α is required for development and progression of KRAS-Mutant Lung Adenocarcinoma M Vreka, I Lilis, M Papageorgopoulou, GA Giotopoulou, M Lianou, ... Cancer research 78 (11), 2939-2951, 2018 | 42 | 2018 |
| NRAS destines tumor cells to the lungs AD Giannou, A Marazioti, NI Kanellakis, I Giopanou, I Lilis, DE Zazara, ... EMBO molecular medicine 9 (5), 672-686, 2017 | 38 | 2017 |
| Myeloid-derived interleukin-1β drives oncogenic KRAS-NF-κΒ addiction in malignant pleural effusion A Marazioti, I Lilis, M Vreka, H Apostolopoulou, A Kalogeropoulou, ... Nature communications 9 (1), 1-16, 2018 | 37 | 2018 |
| Tumor-derived osteopontin isoforms cooperate with TRP53 and CCL2 to promote lung metastasis I Giopanou, I Lilis, V Papaleonidopoulos, T Agalioti, NI Kanellakis, ... Oncoimmunology 6 (1), e1256528, 2017 | 35 | 2017 |
| Efficacy of sonographic and biological pleurodesis indicators of malignant pleural effusion (SIMPLE): protocol of a randomised controlled trial I Psallidas, HEG Piotrowska, A Yousuf, NI Kanellakis, G Kagithala, ... BMJ open respiratory research 4 (1), 2017 | 20 | 2017 |
| Tobacco chemical-induced mouse lung adenocarcinoma cell lines pin the prolactin orthologue proliferin as a lung tumour promoter NI Kanellakis, AD Giannou, MAA Pepe, T Agalioti, DE Zazara, I Giopanou, ... Carcinogenesis 40 (11), 1352-1362, 2019 | 16 | 2019 |
| Osteopontin drives KRAS-mutant lung adenocarcinoma I Giopanou, NI Kanellakis, AD Giannou, I Lilis, A Marazioti, M Spella, ... Carcinogenesis 41 (8), 1134-1144, 2020 | 14 | 2020 |
| Clinically important associations of pleurodesis success in malignant pleural effusion: Analysis of the TIME1 data set RM Mercer, J Macready, H Jeffries, N Speck, NI Kanellakis, NA Maskell, ... Respirology 25 (7), 750-755, 2020 | 10 | 2020 |
| Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients NI Kanellakis, JM Wrightson, R Hallifax, EO Bedawi, R Mercer, M Hassan, ... BMJ open respiratory research 6 (1), e000440, 2019 | 9 | 2019 |
| Intercostal vessel screening prior to pleural interventions by the respiratory physician: a prospective study of real world practice EO Bedawi, A Talwar, M Hassan, DJ McCracken, R Asciak, RM Mercer, ... European Respiratory Journal 55 (4), 2020 | 8 | 2020 |
| Targeted therapies for lung cancer: how did the game begin? NI Kanellakis, T Jacinto, I Psallidas Breathe 12 (2), 177-179, 2016 | 5 | 2016 |
| S129 Does inflammation predict successful pleurodesis? a post hoc analysis from the time 1 trial RM Mercer, J Macready, H Jeffries, N Speck, N Kanellakis, N Maskell, ... Thorax 72 (Suppl 3), A77-A78, 2017 | 4 | 2017 |
